The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

San Diego-based Dexcom, a leading diabetes technology company known for its wearable glucose monitors, is expanding its NIL ...

Mark Andrews breaks silence on playoff drop at fund raiser for his new NIL fund dedicated to athletes with diabetes.

NEW YORK, April 22, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DexCom, Inc. (NASDAQ: DXCM ) breached their ...

Here are four promising growth stocks that can help increase the value of your investment portfolio. The post Looking for ...

Pro soccer striker Marlee Fray is leading the charge for the next generation of college sports stars with diabetes in new NIL ...

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the return of Dexcom U – its ...

After that drop, Andrews drew heated criticism and threats on social media. In an effort to support Andrews, Bills fans ...

Global sensation Nick Jonas has always been open about his health journey, and recently, the singer reflected on being ...

Medtronic plc’s diabetes unit posted another win with the U.S. FDA approval of the Simplera continuous glucose monitoring sensor for use with the Minimed 780G pump system, helping the company catch up ...

Shares of DexCom Inc. DXCM slid 3.59% to $66.11 Monday, on what proved to be an all-around rough trading session for the ...